Rivoire M, De Cian F, Meeus P, Gignoux B, Fréring B, Kaemmerlen P
Department of Surgery, Centre Léon Bérard, 28, Rue Laënnec, 69373 Lyon, France.
Anticancer Res. 2000 Sep-Oct;20(5C):3785-90.
The aim of the study was to evaluate the results of cryosurgery in patients with multiple (five or more), heavily pretreated, unresectable liver metastases.
Nineteen patients with multiple unresectable liver metastases were entered into a prospective nonrandomized trial. The liver tumours were treated during surgery under ultrasound guidance. All the patients were followed-up to assess complications, treatment response and sites of recurrence.
140 metastases were identified in 19 patients (mean, 7; range, 5-25) and 13 patients had a synchronous liver resection. Cryosurgery was used to treat 90 metastases (mean diameter, 30 mm; range, 10-135). There were no treatment-related deaths and the overall rate of complications was 21%. During a mean follow-up of 28 months (range, 5-60), tumours recurred at the site of cryosurgery in two patients (10%), in the remaining liver in nine patients (47%) and elsewhere in five patients (26%). Three patients had no evidence of disease 48, 50 and 60 months after liver cryosurgery, respectively.
Cryosurgery may be effective in the treatment of patients with multiple unresectable liver metastases and should be investigated in multimodality treatment programmes.
本研究的目的是评估冷冻手术治疗多发(五个或更多)、经过大量预处理且无法切除的肝转移瘤患者的效果。
19例无法切除的多发肝转移瘤患者进入一项前瞻性非随机试验。肝肿瘤在超声引导下于手术中进行治疗。所有患者均接受随访以评估并发症、治疗反应和复发部位。
19例患者共发现140个转移瘤(平均7个;范围5 - 25个),13例患者同期进行了肝切除术。冷冻手术用于治疗90个转移瘤(平均直径30毫米;范围10 - 135毫米)。无治疗相关死亡,并发症总发生率为21%。在平均28个月(范围5 - 60个月)的随访期间,2例患者(10%)在冷冻手术部位复发肿瘤,9例患者(47%)在剩余肝脏复发,5例患者(26%)在其他部位复发。3例患者在肝脏冷冻手术后48、50和60个月分别无疾病证据。
冷冻手术可能对多发无法切除的肝转移瘤患者有效,应在多模式治疗方案中进行研究。